two significant new approaches for treating and preventing breast cancer
October 1998
The FDA is close to approving two significant new approaches for treating and preventing breast cancer.
Herceptin (trastuzumab) will be a major breakthrough...it's the first monoclonal antibody for treating metastatic breast cancer.
It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumors that produce excessive amounts of HER2.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote